Evidence map›Paper›PMID 35625554›Full record

ReviewBiomolecules2022

Therapeutic Effects of Citrus Flavonoids Neohesperidin, Hesperidin and Its Aglycone, Hesperetin on Bone Health.

Adriana de Cássia Ortiz, Simone Ortiz Moura Fideles, Carlos Henrique Bertoni Reis, Márcia Zilioli Bellini, Eliana de Souza Bastos Mazuqueli Pereira, João Paulo Galletti Pilon, Miguel Ângelo de Marchi, Cláudia Rucco Penteado Detregiachi, Uri Adrian Prync Flato, Beatriz Flavia de Moraes Trazzi and 6 more

Open access · goldAbstract readReview
In one paragraph

Review in Biomolecules, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 50 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
50citing papers in PubMed, 2 pooled it
7.8field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

50 citing papers in PubMed, 2 syntheses or guidelines pooled it, 92 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Hesperetin mitigates IBD-associated bone loss viaJournal of orthopaedic translation · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Beneficial effects ofPharmaceutical biology · 2025
    Review
  13. Review
  14. Article
  15. Review
  16. Review
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 3 institutions in 1 country.

Adriana de Cássia OrtizDepartment of Biological Sciences, Bauru School of Dentistry (FOB/USP), University of São Paulo, Bauru 17012-901, Brazil.ORCID 0000-0002-0783-3246
Simone Ortiz Moura FidelesDepartment of Biological Sciences, Bauru School of Dentistry (FOB/USP), University of São Paulo, Bauru 17012-901, Brazil.
Carlos Henrique Bertoni ReisDepartment of Biological Sciences, Bauru School of Dentistry (FOB/USP), University of São Paulo, Bauru 17012-901, Brazil.
Márcia Zilioli BelliniPro-Rectory of Research and Graduate Studies, University Center of Adamantina (UniFAI), Adamantina 17800-000, Brazil.
Eliana de Souza Bastos Mazuqueli PereiraPostgraduate Program in Structural and Functional Interactions in Rehabilitation, Postgraduate Department, University of Marilia (UNIMAR), Marília 17525-902, Brazil.
João Paulo Galletti PilonUNIMAR Beneficent Hospital (HBU), Faculty of Medicine, University of Marilia (UNIMAR), Marília 17525-160, Brazil.
Miguel Ângelo de MarchiCoordination of the Medical School, University Center of Adamantina (UniFAI), Adamantina 17800-000, Brazil.
Cláudia Rucco Penteado DetregiachiPostgraduate Program in Structural and Functional Interactions in Rehabilitation, Postgraduate Department, University of Marilia (UNIMAR), Marília 17525-902, Brazil.
Uri Adrian Prync FlatoUNIMAR Beneficent Hospital (HBU), Faculty of Medicine, University of Marilia (UNIMAR), Marília 17525-160, Brazil.
Beatriz Flavia de Moraes TrazziCoordination of the Dentistry School, University of Marilia (UNIMAR), Marília 17525-902, Brazil.
Bruna Trazzi PaganiDentistry School, University of Marilia (UNIMAR), Marília 17525-902, Brazil.
José Burgos PonceMedicine Department, University Center of Adamantina (UniFAI), Adamantina 17800-000, Brazil.
Taiane Priscila GardizaniMedicine Department, University Center of Adamantina (UniFAI), Adamantina 17800-000, Brazil.
Fulvia de Souza VeronezPro-Rectory of Teaching, University Center of Adamantina (UniFAI), Adamantina 17800-000, Brazil.
Daniela Vieira BuchaimPostgraduate Program in Structural and Functional Interactions in Rehabilitation, Postgraduate Department, University of Marilia (UNIMAR), Marília 17525-902, Brazil.ORCID 0000-0002-9914-1262
Rogerio Leone BuchaimDepartment of Biological Sciences, Bauru School of Dentistry (FOB/USP), University of São Paulo, Bauru 17012-901, Brazil.ORCID 0000-0002-5881-2218
Universidade de Marília · BRSolução Ambiental Assessoria e Consultoria · BRUniversidade de São Paulo · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Flavonoids are natural phytochemicals that have therapeutic effects and act in the prevention of several pathologies. These phytochemicals can be found in seeds, grains, tea, coffee, wine, chocolate, cocoa, vegetables and, mainly, in citrus fruits. Neohesperidin, hesperidin and hesperetin are citrus flavonoids from the flavanones subclass that have anti-inflammatory and antioxidant potential. Neohesperidin, in the form of neohesperidin dihydrochalcone (NHDC), also has dietary properties as a sweetener. In general, these flavanones have been investigated as a strategy to control bone diseases, such as osteoporosis and osteoarthritis. In this literature review, we compiled studies that investigated the effects of neohesperidin, hesperidin and its aglycone, hesperetin, on bone health. In vitro studies showed that these flavanones exerted an antiosteoclastic and anti- inflammatory effects, inhibiting the expression of osteoclastic markers and reducing the levels of reactive oxygen species, proinflammatory cytokines and matrix metalloproteinase levels. Similarly, such studies favored the osteogenic potential of preosteoblastic cells and induced the overexpression of osteogenic markers. In vivo, these flavanones favored the regeneration of bone defects and minimized inflammation in arthritis- and periodontitis-induced models. Additionally, they exerted a significant anticatabolic effect in ovariectomy models, reducing trabecular bone loss and increasing bone mineral density. Although research should advance to the clinical field, these flavanones may have therapeutic potential for controlling the progression of metabolic, autoimmune or inflammatory bone diseases.

Indexed as

CitrusFlavanonesHesperidinOsteoporosisBone DensityFlavonoidsFlavanonesFlavonoidshesperetinHesperidinneohesperidinbonebone healthbone repairflavonoidshesperetinhesperidinneohesperidin

Identifiers

PMID35625554
PMCPMC9138288
OpenAlexW4224311053

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.